Early blood pressure assessment after acute myocardial infarction: Insights using digital health technology

Rongzi Shan, Jie Ding, Daniel Weng, Erin M Spaulding, Shannon Wongvibulsin, Matthias A Lee, Ryan Demo, Francoise A Marvel, Seth S Martin, Rongzi Shan, Jie Ding, Daniel Weng, Erin M Spaulding, Shannon Wongvibulsin, Matthias A Lee, Ryan Demo, Francoise A Marvel, Seth S Martin

Abstract

Objective: There is rising interest in digital health in preventive cardiology, particularly for blood pressure (BP) management. In a digital health study of early BP assessment following acute myocardial infarction (AMI), we sought to examine feasibility and the (1) proportion of post-AMI patients with controlled BP and hypotension, and (2) association between prior cardiovascular disease (CVD) and BP post-AMI.

Methods: In this substudy of the parent Myocardial infarction, COmbined-device, Recovery Enhancement (MiCORE) study, type 1 AMI patients were enrolled between October 2017 and April 2019. Participants self-monitored their BP through 30 days after hospital discharge using an FDA-approved wireless BP monitor connected with a smartphone application. Linear mixed-effects models assessed the association between prior CVD and BP trajectory post-discharge, adjusting for antihypertensive medications and a propensity score inclusive of CVD risk factors.

Results: Sixty-eight AMI patients (mean age 58 ​± ​10 years, 75% male, 68% white race, 68% history of hypertension, 24% prior CVD) provided 2638 measurements over 30 days. The percentage of BP control <130/80 ​mmHg was 59.6% (95% CI: 54.3-64.9%) and <140/90 ​mmHg was 83.7% (95% CI: 80.3-87.2%). The percentage of systolic BP ​<90 ​mmHg was 1.1% (95% CI: 0.17-2.0%) and the percentage of diastolic BP ​<60 ​mmHg was 3.9% (95% CI: 2.6-5.2%). Prior CVD was associated with 12.2 ​mmHg higher mean daily systolic BP during admission (95% CI: 3.5-20.9 ​mmHg), which persisted over follow-up. There was no association between prior CVD and diastolic BP.

Conclusion: The digital health program was feasible and ~40% of post-AMI patients who engaged in it had uncontrolled BP according to recent guideline cutpoints, while hypotension occurred rarely. The gap in BP control was especially large in patients in whom AMI represented recurrent CVD. These data suggest an opportunity for more aggressive secondary prevention early after MI as care models integrate digital health.

Keywords: Blood pressure; Digital health; Myocardial infarction; Secondary prevention; Smartphone.

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Corrie Health, as described in this work, was developed by FAM, MAL, and SSM . They are also founders of and hold equity in Corrie Health, which intends to further develop the digital platform. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. SSM has served as a consultant to Akcea, Amgen, Astra Zeneca, Esperion, Kaneka, Novo Nordisk, Quest Diagnostics, Sanofi, Regeneron, and REGENXBIO.

© 2020 The Authors.

Figures

Fig. 1
Fig. 1
Data flow. MiCORE denotes Myocardial infarction, COmbined-device, Recovery Enhancement (the parent study for this analysis); BP blood pressure; AMI acute myocardial infarction.
Fig. 2
Fig. 2
Distribution of time of day of self-selected home blood pressure recording. Total number of recordings ​= ​2488. Time periods are defined as follows: Night/Early Morning (0000–0759), Morning (0800–1159), Noon/Afternoon (1200–1559), Late Afternoon/Evening (1600–1959), and Evening/Night (2000–2359).
Fig. 3
Fig. 3
Predicted trajectories of average daily systolic blood pressure (BP) values over 30-day post discharge, by prior cardiovascular disease (CVD) status. Study day 0 represents mean systolic BP during the admission period. Trajectories of mean BP values on each follow-up day were predicted using a linear mixed-effects model, which was adjusted for CVD propensity score, number of antihypertensive medications, and the interaction term between prior CVD and study day. Number of participants ​= ​68; number of observations ​= ​1197.

References

    1. Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P. On behalf of the AHAC on E and PS, Association. C and SSS. Heart disease and stroke statistics- 2020 update: a report from the American heart association. Circulation. 2020;141:e1–e45. doi: 10.1161/CIR.0000000000000757. Available at: doi:
    1. Smith S.C., Benjamin E.J., Bonow R.O., Braun L.T., Creager M.A., Franklin B.A. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation. 2011;124:2458–2473. Available at:
    1. Shimbo D., Artinian N.T., Basile J.N., Krakoff L.R., Margolis K.L., Rakotz M.K. Self-measured blood pressure monitoring at home: a joint policy statement from the American heart association and American medical association. Circulation. 2020 Available at:
    1. Whelton P.K., Carey R.M., Aronow W.S., Casey D.E., Collins K.J., Dennison Himmelfarb C. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018:71. Available at:
    1. Casey D.E., Thomas R.J., Bhalla V., Commodore-Mensah Y., Heidenreich P.A., Kolte D. 2019 AHA/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of cardiology/American heart association task force on performance measures. Circ Cardiovasc Qual Outcomes. 2019;12 Available at:
    1. Gandhi S., Chen S., Hong L., Sun K., Gong E., Li C. Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Can J Cardiol. 2017;33:219–231. Available at:
    1. Uhlig K., Patel K., Ip S., Kitsios G.D., Balk E.M. Self-measured blood pressure monitoring in the management of hypertension A systematic review and meta-analysis. Ann Intern Med. 2013;159:185–194. Available at:
    1. Franklin G.A., Boaz P.W., Spain D.A., Lukan J.K., Carrillo E.H., Richardson J.D. Vol. 48. Lippincott Williams and Wilkins; 2000. Prehospital hypotension as a valid indicator of trauma team activation; pp. 1034–1039. (Journal of trauma - injury, infection and critical care).
    1. Rahman F., McEvoy J.W. The J-shaped curve for blood pressure and cardiovascular disease risk: historical context and recent updates. Curr Atherosclerosis Rep. 2017;19
    1. Spaulding E.M., Marvel F.A., Lee M.A., Yang W.E., Demo R., Wang J. Corrie health digital platform for self-management in secondary prevention after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2019;12 Available at:
    1. Yang W.E., Spaulding E.M., Lumelsky D., Hung G., Huynh P.P., Knowles K. Strategies for the successful implementation of a novel iPhone Loaner System (iShare) in mHealth interventions: prospective study. JMIR mHealth uHealth. 2019;7 Available at:
    1. Hung G., Yang W.E., Marvel F.A., Martin S.S. Mobile health application platform a € Corrie’ personalises and empowers the heart attack recovery patient experience in the hospital and at home for an underserved heart attack survivor. BMJ Case Rep. 2020:13. Available at:
    1. Shang F., Zhu Y., Zhu Z., Liu L., Wan Y. Vol. 18. Blood Press Monit; 2013. pp. 278–281. (Validation of the iHealth BP5 wireless upper arm blood pressure monitor for self-measurement according to the European Society of Hypertension International Protocol revision 2010). Available at:
    1. Goff D.C., Lloyd-Jones D.M., Bennett G., Coady S., D’Agostino R.B., Gibbons R. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129:S49–S73. Available at:
    1. Lee T.C., Cavalcanti R.B., McDonald E.G., Pilote L., Brophy J.M. Diastolic hypotension may attenuate benefits from intensive systolic targets: secondary analysis of a randomized controlled trial. Am J Med. 2018;131:1228–1233.e1.
    1. Park H., Hong Y.J., Cho J.Y., Sim D.S., Yoon H.J., Kim K.H. Korean acute myocardial infarction registry investigators KAMIR. Blood pressure targets and clinical outcomes in patients with acute myocardial infarction. Korean Circ J. 2017;47:446–454. Available at:
    1. Thune J.J., Signorovitch J., Kober L., Velazquez E.J., McMurray J.J.V., Califf R.M. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension. 2008;51:48–54.
    1. Roth D., Tulder R Van, Heidinger B., Herkner H., Schreiber W., Havel C. Admission blood pressure and 1-year mortality in acute myocardial infarction. Int J Clin Pract. 2015;69:812–819. Available at:
    1. Denardo S.J., Gong Y., Nichols W.W., Messerli F.H., Bavry A.A., Cooper-DeHoff R.M. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123:719–726. Available at:
    1. Giles T.D. Circadian rhythm of blood pressure and the relation to cardiovascular events. J Hypertens. 2006;24:S11–S16. Available at:
    1. Postel-Vinay N., Bobrie G., Savard S., Persu A., Amar L., Azizi M. Home blood pressure measurement and digital health: communication technologies create a new context. J Hypertens. 2018:1. Available at:
    1. Plante T.B., Urrea B., MacFarlane Z.T., Blumenthal R.S., Miller E.R., Appel L.J. Validation of the instant blood pressure smartphone app. JAMA Intern Med. 2016;176 700–2. Available at:
    1. Milani R.V., Lavie C.J., Bober R.M., Milani A.R., Ventura H.O. Improving hypertension control and patient engagement using digital tools. Am J Med. 2017;130:14–20.
    1. Treskes R.W., van Winden L.A.M., van Keulen N., van der Velde E.T., Beeres S.L.M.A., Atsma D.E. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial. JAMA Netw Open. 2020;3:e202165.
    1. Treskes R.W., Wolterbeek R., van der Velde E.T., Eindhoven D.C., Schalij M.J. Comparison of the diagnostic accuracy of four smartphone-compatible blood pressure monitors in post-myocardial infarction patients. J Telemed Telecare. 2018;24:404–409. Available at:
    1. Pew Research Center . 2019. Demographics of mobile device ownership and adoption in the United States. Available at:
    1. Wosik J., Fudim M., Cameron B., Gellad Z.F., Cho A., Phinney D. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inf Assoc. 2020;27:957–962. Available at:

Source: PubMed

3
購読する